Takhzyro

List of products in the National Drug Code with proprietary name takhzyro. This medication is used to help prevent severe swelling attacks due to a certain inherited immune disease (hereditary angioedema-HAE). Lanadelumab-flyo works by binding to a natural substance made by the body (kallikrein) and blocking its effect. This blocking effect lowers the amount of another natural substance (bradykinin) that causes symptoms during an attack of HAE. Lanadelumab-flyo may help decrease symptoms such as abdominal pain/cramps, diarrhea, vomiting, or rapid swelling and pain of the hands, feet, limbs, face, tongue, or throat.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
47783-644Takhzyro Lanadelumab-flyoInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug
47783-645Takhzyro Lanadelumab-flyoSolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug
47783-646Takhzyro Lanadelumab-flyoSolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug